Risk factor
Strong & resilient to price shocks
Profitability factor
Overvalued vs peers
About
Valiant Co.,Ltd. produces and sells chemical materials worldwide. The company offers liquid crystal singles and intermediates, OLED singles and intermediates, PI materials, PR monomer, lithium battery additives, and other electronic chemicals. It also provides automobile exhausts purification materials, flue gas denitrification catalysts, VOCs adsorption catalysts, methanol to olefin catalysts, petroleum cracking catalysts, new energy materials, energy-saving lighting materials, organic solar technology, other supporting materials for new energy vehicles, etc. In addition, the company offers API, pharmaceutical intermediates, pharmaceutical formulations, Chinese medicine, and nutrition and health food; life science products related to drug innovation, genomics, proteomics, metabonomics, food health analysis, etc.; and diagnostic reagent products used for the diagnosis of human diseases, such as AIDS, hepatitis, cancer, dengue, cardiovascular and cerebrovascular diseases, etc., as well as for the detection of drug abuse, endocrine levels, and other human conditions. The company was formerly known as Yantai Valiant Fine Chemicals Co., Ltd. and changed its name to Valiant Co.,Ltd. in May 2015. Valiant Co.,Ltd. was founded in 1992 and is headquartered in Yantai, China.
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is overpriced on P/E, of fair value on EV/EBITDA,
Target Price
The average target price of 002643.SZ is 22 and suggests 26% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc